Super excited for tomorrow's ER Guidance Call for our first ever FDA approved commercialized product, Briumvi!

$TGTX Good TG week, nice to see the trend continue since approval. 😎🙏😎

They're FDA approved, have the best in class treatment, and is more affordable than the others.

Best drug approval of 2022.

Freshly approved drug and undervalued would mean the JP conference should be ideal for us.

$AUPH regardless of where the market goes 2023 will be a very good year for $AUPH and $TGTX Both having best in class block buster potential drugs approved

$TGTX successfully on time launch in Q1 2023 and EU approval mid year, we will be back to highs.

$TGTX is up 13% continued momentum following MS drug approvals.

gets a drug approved and immediately rewards shareholders!!!

$PRVB 8.60 to 8.80 has been good support since approval.

If that gets approved its 10.000 times better than Provention Bio.

Great to see the FDA approval, as well as $SNY commitment.

$PRVB While reaching this milestone of approval has been inspirational, it is now the aspirational goal of population screening which is at the forefront.

It works, there is a need for it, there is insurance buy in on it, there is a global sales team, there is further label expansion and approvals in the future, and there are additional drugs in the pipeline from this company that show the same promise.

PRVB is in a MUCH better financial situation now with FDA approval giving them a multi-billion USD asset (Teplizumab) which they can get conventional financing from A BANK!!

It's APPROVED !!

$PRVB Interesting they received approval which is good.

$PRVB good that they have got an approval.

This should have no problem getting approved.

This is 100% normal and part of the growth of a strong company with excellent fundamentals and an FDA approval coming this year.

Better than money in the bank with soon resubmission and approval 2-6 months later!

Going to be an absolute banger when Xphozah gets approved.

And this is just a beginning, FDA approval will take it to the skies.

Perfect setup for Tenapanor approval.

$AKBA within 3 to 4 weeks this stock could be over 2 heading to three like $ARDX .. gsk approval has helped.. fda news, ema opinion/ approval, partnership..

$ARDX This company is sitting on a mountain of great fundamentals.. 40++ medical patents ,,, 40+ more in application status 1 drug approved IBSRELA 1 drug almost aproved XPHOZAH a kidney drug that could pull an annual billion dollar + revenue.

$ARDX when we get fda approval will be shining